GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NutraLife Biosciences Inc (OTCPK:NLBS) » Definitions » Deferred Tax

NutraLife Biosciences (NutraLife Biosciences) Deferred Tax : $0.00 Mil (TTM As of Sep. 2022)


View and export this data going back to 2014. Start your Free Trial

What is NutraLife Biosciences Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

NutraLife Biosciences's change in deferred tax for the three months ended in Sep. 2022 was $0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Sep. 2022 was $0.00 Mil.


NutraLife Biosciences Deferred Tax Historical Data

The historical data trend for NutraLife Biosciences's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NutraLife Biosciences Deferred Tax Chart

NutraLife Biosciences Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

NutraLife Biosciences Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

NutraLife Biosciences Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NutraLife Biosciences Deferred Tax Related Terms

Thank you for viewing the detailed overview of NutraLife Biosciences's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.


NutraLife Biosciences (NutraLife Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
6601 Lyons Road, Suite L-6, Coconut Creek, FL, USA, 33073
NutraLife BioSciences Inc is engaged in the development, manufacturing and distribution of nutritional and dietary nutritional supplement products. The company is a branded and private label developer, manufacturer and distributor of a wide range of nutraceutical, wellness, and CBD products. It's private-label ingestible and skincare products include CBD-infused oral sprays, tinctures, pet drops, pain balms, and face creams. Its CBD products are derived from the seeds and mature stalks of the Cannabis Sativa plant which includes all parts and varieties of the cannabis sativa plant also known as hemp, which contain a tetrahydrocannabinol concentration.
Executives
Edgar Ward director, 10 percent owner, officer: President and CEO 5851 HOLMBERG RD., UNIT 2511, PARKLAND FL 33067
Neil Catania 10 percent owner, officer: Vice President 5 FIREPLACE CT., EAST NORTHPORT NY 11731
Lee White 10 percent owner, other: 10% Shareholder 130 S. RD., PAGET D0 PG06

NutraLife Biosciences (NutraLife Biosciences) Headlines